BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 2542967)

  • 1. Evidence that the familial adenomatous polyposis gene is involved in a subset of colon cancers with a complementable defect in c-myc regulation.
    Erisman MD; Scott JK; Astrin SM
    Proc Natl Acad Sci U S A; 1989 Jun; 86(11):4264-8. PubMed ID: 2542967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the oncogene c-myc in sporadic large bowel cancer and familial polyposis coli.
    Rothberg PG
    Semin Surg Oncol; 1987; 3(3):152-8. PubMed ID: 2821605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of deregulated c-MYC expression in human colon carcinoma cells by chromosome 5 transfer.
    Rodriguez-Alfageme C; Stanbridge EJ; Astrin SM
    Proc Natl Acad Sci U S A; 1992 Feb; 89(4):1482-6. PubMed ID: 1741403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Colonic polyposis and cancers of the colon. Molecular markers, predisposition and diagnosis of familial forms].
    Grandjouan S
    Bull Cancer; 1991 Jan; 78(1):85-90. PubMed ID: 1850632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic changes and histopathological types in colorectal tumors from patients with familial adenomatous polyposis.
    Miyaki M; Seki M; Okamoto M; Yamanaka A; Maeda Y; Tanaka K; Kikuchi R; Iwama T; Ikeuchi T; Tonomura A
    Cancer Res; 1990 Nov; 50(22):7166-73. PubMed ID: 1977514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular nature of chromosome 5q loss in colorectal tumors and desmoids from patients with familial adenomatous polyposis.
    Okamoto M; Sato C; Kohno Y; Mori T; Iwama T; Tonomura A; Miki Y; Utsunomiya J; Nakamura Y; White R
    Hum Genet; 1990 Oct; 85(6):595-9. PubMed ID: 2172153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The c-myc protein is constitutively expressed at elevated levels in colorectal carcinoma cell lines.
    Erisman MD; Scott JK; Watt RA; Astrin SM
    Oncogene; 1988 Apr; 2(4):367-78. PubMed ID: 3283655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosome 5 allele loss in human colorectal carcinomas.
    Solomon E; Voss R; Hall V; Bodmer WF; Jass JR; Jeffreys AJ; Lucibello FC; Patel I; Rider SH
    Nature; 1987 Aug 13-19; 328(6131):616-9. PubMed ID: 2886919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-myc overexpression is a tumor-specific phenomenon in a subset of human colorectal carcinomas.
    Viel A; Maestro R; Toffoli G; Grion G; Boiocchi M
    J Cancer Res Clin Oncol; 1990; 116(3):288-94. PubMed ID: 2196264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of c-myc gene and c-fos gene in premalignant and malignant tissues from patients with familial polyposis coli.
    Sugio K; Kurata S; Sasaki M; Soejima J; Sasazuki T
    Cancer Res; 1988 Sep; 48(17):4855-61. PubMed ID: 2842040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic analysis of an inherited predisposition to colon cancer in a family with a variable number of adenomatous polyps.
    Leppert M; Burt R; Hughes JP; Samowitz W; Nakamura Y; Woodward S; Gardner E; Lalouel JM; White R
    N Engl J Med; 1990 Mar; 322(13):904-8. PubMed ID: 2156161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivation of Adenomatous Polyposis Coli Reduces Bile Acid/Farnesoid X Receptor Expression through Fxr gene CpG Methylation in Mouse Colon Tumors and Human Colon Cancer Cells.
    Selmin OI; Fang C; Lyon AM; Doetschman TC; Thompson PA; Martinez JD; Smith JW; Lance PM; Romagnolo DF
    J Nutr; 2016 Feb; 146(2):236-42. PubMed ID: 26609171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of c-MYC and c-MYB proto-oncogenes is associated with decreased apoptosis in tumor colon progression.
    Greco C; Alvino S; Buglioni S; Assisi D; Lapenta R; Grassi A; Stigliano V; Mottolese M; Casale V
    Anticancer Res; 2001; 21(5):3185-92. PubMed ID: 11848471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal distribution of c-myc oncogene product in familial adenomatous polyposis.
    Sundaresan V; Forgacs IC; Wight DG; Wilson B; Evan GI; Watson JV
    J Clin Pathol; 1987 Nov; 40(11):1274-81. PubMed ID: 2826545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic changes of both p53 alleles associated with the conversion from colorectal adenoma to early carcinoma in familial adenomatous polyposis and non-familial adenomatous polyposis patients.
    Kikuchi-Yanoshita R; Konishi M; Ito S; Seki M; Tanaka K; Maeda Y; Iino H; Fukayama M; Koike M; Mori T
    Cancer Res; 1992 Jul; 52(14):3965-71. PubMed ID: 1319835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of chromosome 6 allele loss in human colorectal carcinomas.
    Wildrick DM; Alfaro SR; Gope R; Boman BM
    Anticancer Res; 1992; 12(5):1717-9. PubMed ID: 1332582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of constitutional heterozygosity in colon carcinoma from patients with familial polyposis coli.
    Okamoto M; Sasaki M; Sugio K; Sato C; Iwama T; Ikeuchi T; Tonomura A; Sasazuki T; Miyaki M
    Nature; 1988 Jan; 331(6153):273-7. PubMed ID: 2827040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interstitial loss of the same region of 5q in multiple adenomas and a carcinoma derived from an adenomatous polyposis coli (APC) patient.
    Miki Y; Nishisho I; Miyoshi Y; Utsunomiya J; Nakamura Y
    Genes Chromosomes Cancer; 1992 Jan; 4(1):81-3. PubMed ID: 1377014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic analysis of colorectal cancer.
    Bodmer WF; Cottrell S; Frischauf AM; Kerr IB; Murday VA; Rowan AJ; Smith MF; Solomon E; Thomas H; Varesco L
    Princess Takamatsu Symp; 1989; 20():49-59. PubMed ID: 2562187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [From gene to disease; the APC gene and familial adenomatous polyposis coli].
    van der Luijt RB; Tops CM; Vasen HF
    Ned Tijdschr Geneeskd; 2000 Oct; 144(42):2007-9. PubMed ID: 11072519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.